Analysis of the domestic pharmaceutical market of psychostimulants and nootropic drugs of N06BX group
DOI:
https://doi.org/10.24959/uekj.20.25Keywords:
n-phenyl-acetyl-L-prolylglycine, nootropics, market analysis, cerebroprotectorsAbstract
Aim. To study the nomenclature of synthetic and herbal N06BX group, presented on the pharmaceutical market ofUkraine.
Results. According to the State Expert Center of the Ministry of Health of Ukraine, the pharmaceutical market of Ukraine presents 14 international non-proprietary names (INN) of drugs or 214 trade names of drugs, including forms of release registered as of the classification of ATC; December, 2019. The range of these drugs has been represented by drugs analogues, both synthetic and herbal. In total, according to the list of N06BX group, there are 29 countries producing drugs of this group.
Conclusions. The market of N06BX group inUkraine has been analyzed and it has been established that drugs of domestic production occupy 52.91 %, foreign – 39.68 %, joint ventures of Ukrainian producers with foreign – 7.41 %. The main market share in the general nomenclature of the N06BX group belongs to the following manufacturers: PJSC Farmak, LLC Pharmaceutical Company Zdorovya and PJSC Pharmaceutical Firm Darnytsia. Among foreign manufacturers, the leaders are – manufacturers fromLatvia,Poland andHungary. It should be noted that pharmaceutical market ofUkraine presents 5 joint ventures with foreign countries producing drugs of N06BX group. As active substances used: citicoline, vinpocetine, piracetam, phenibut, mebicar and herbal preparations of the Ginkgo Biloba group. Release forms: solutions for injections, drops for oral use, tablets, capsules. Taking into account the lack of registered dosage forms of n-phenyl-acetyl-L-prolylglycine on the domestic market, as well as the prospects of using a nasal dosage form for transporting the active substance directly into the brain, it is advisable to conduct further research.
References
Gudasheva, T. A., Ostrovskaya, R. U., Seredenin, S. B. (2018). Novel Technologies for Dipeptide Drugs Design and their Implantation. Current pharmaceutical design, 24 (26), 3020-3027. doi: https://doi.org/10.2174/1381612824666181008105641
Savelieva, O. V., Shumova, H. S., Vladymyrova,I.M. (2015). ScitnceRise, 14 (4), 30–36. doi: https://doi.org/10.15587/2313-8416.2015.54873
Vostrikov, V. V. (2017). Obzory Po Klinicheskoi Farmakolohii i Lekarstvennoi Terapii, 15 (1), 14–25. doi: 10.17816/RCF15114-25
Suliman, N. A., Mat Taib, C. N., Mohd Moklas, M. A., Adenan, M. I., Hidayat Baharuldin, M. T., Basir, R. (2016) Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-based complementary and alternative medicine,1-12. doi: https://doi.org/10.1155/2016/4391375
Belenichev,I.F. (2014). Neiroprotektsiia i neiroplastichnost. Kiyev: Poligraf plius, 512.
Kashyap, K., Shukla, R. (2019). Drug Delivery and Targeting to the Brain ThroughNasal Route: Mechanisms, Applications and Challenges. Curr Drug Deliv, 16 (10), 887-901. doi: https://doi.org/10.2174/1567201816666191029122740
Talih, F., Ajaltouni, J. (2015). Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases. Innovations in clinical neuroscience, 12 (11-12), 21–25.
Winblad, B. (2005). Piracetam: A Review of Pharmacological Properties and Clinical Uses. CNS Drug Reviews, 11, 169-182. doi: https://doi.org/10.1111/j.1527-3458.2005.tb00268.x
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: www.drlz.kiev.ua.
Abdulkarim, A. N., Bushuieva,I.V., Hladysheva, S. A. (2018). Aktualni Pytannia Farmatsevtychnoi i Medychnoi Nauky Ta Praktyky, 11 (3), 339–345. doi: 10.14739/2409-2932.2018.3.145256
Frati, P., Kyriakou, C.,Del Rio, A., Marinelli, E., Vergallo, G. M., Zaami, S., Busardò, F. P. (2015). Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology. Current neuropharmacology, 13 (1), 5–11. doi: https://doi.org/10.2174/1570159X13666141210221750
Kompendium. Lekarstvennyie preparatyi. Available at: http://сompendium.com.ua/
Downloads
Published
Issue
Section
License
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
